Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Assets Average (2012 - 2026)

Verastem (VSTM) posted quarterly Assets Average of $237.1 million for Q1 2026, up 103.33% year-over-year from $116.6 million in Q1 2025, and up 12.04% quarter-over-quarter from $211.6 million in Q4 2025.

Analysis

Verastem (VSTM) Assets Average (2012 - 2026) Analysis & Trends

Verastem's Assets Average history runs 15 years deep, the most recent figure standing at $237.1 million for Q1 2026.

  • In Q1 2026, Assets Average rose 103.33% year-over-year to $237.1 million; the TTM figure through Mar 2026 stood at $237.1 million (up 103.33% YoY), while the FY2025 annual figure was $174.0 million, up 38.5% from the prior year.
  • Assets Average for Q1 2026 stood at $237.1 million, up from $211.6 million in the prior quarter.
  • The five-year high for Assets Average was $237.1 million in Q1 2026, with the low at $103.1 million in Q4 2022.
  • The 5-year median for Assets Average is $116.6 million (2025), against an average of $143.4 million.
  • The sharpest annual moves came in 2024 and 2026: Assets Average slumped 36.91% in 2024, then jumped 103.33% in 2026.
  • Verastem's Assets Average stood at $103.1 million in 2022, then soared by 58.08% to $162.9 million in 2023, then plunged by 30.06% to $114.0 million in 2024, then soared by 85.72% to $211.6 million in 2025, then increased by 12.04% to $237.1 million in 2026.
  • Business Quant data shows VSTM's Assets Average at $237.1 million in Q1 2026, $211.6 million in Q4 2025, and $186.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn 217.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 217.16 Mn
Mar 31, 2026 237.13 Mn
Dec 31, 2025 211.65 Mn
Sep 30, 2025 186.56 Mn
Jun 30, 2025 163.98 Mn
Mar 31, 2025 116.62 Mn
Dec 31, 2024 113.96 Mn
Sep 30, 2024 116.06 Mn
Jun 30, 2024 114.64 Mn
Mar 31, 2024 136.63 Mn
Dec 31, 2023 162.94 Mn
Sep 30, 2023 183.96 Mn
Jun 30, 2023 156.32 Mn
Mar 31, 2023 107.96 Mn
Dec 31, 2022 103.07 Mn
Sep 30, 2022 105.75 Mn
Jun 30, 2022 108.28 Mn
Mar 31, 2022 112.41 Mn
Dec 31, 2021 110.27 Mn
Sep 30, 2021 117.88 Mn